MDLA Secures IFC Investment to Strengthen Company Fundamentals

PT Medela Potentia Tbk (MDLA), a leading healthcare holding company with over four decades of experience, has secured a strategic equity investment from the International Finance Corporation (IFC) through its Initial Public Offering (IPO), officially listed on the Indonesia Stock Exchange (IDX) on April 15, 2025.

IFC’s investment of Rp197 billion will accelerate MDLA’s initiatives to expand its national distribution network, enhance local manufacturing of medical devices, and modernize its logistics infrastructure with advanced technology solutions.

This partnership aligns with Indonesia’s healthcare transformation agenda to strengthen the industry’s resilience and reduce dependence on imported healthcare products.

"We are honored to have IFC’s support as we embark on this important milestone,” said Krestijanto Pandji, President Director of PT Medela Potentia Tbk. “This investment reinforces our commitment to expanding access to high-quality healthcare and pharmaceutical products and medical devices throughout Indonesia, while continuing to invest in technology, infrastructure, and innovation to meet the country’s growing healthcare needs.”

IFC’s participation reaffirms MDLA’s strong fundamentals, robust corporate governance, and strategic role in advancing healthcare access both domestically and regionally. As one of the few Indonesian healthcare companies entrusted with this mission, MDLA is committed to fostering a more self-reliant, sustainable, and innovation-driven healthcare ecosystem.

IFC Country Manager for Indonesia and Timor-Leste Euan Marshall, emphasized the importance of private sector collaboration in strengthening the healthcare system.

“IFC’s investment reflects our commitment to strengthening Indonesia’s healthcare system,” said Euan Marshall, IFC’s Country Manager for Indonesia and Timor-Leste. “We’re pleased to participate in Medela Potentia’s IPO, which demonstrates how capital markets can be leveraged to support companies that are advancing innovation and delivering long-term impact in critical sectors like healthcare.”

With strong fundamentals and the backing of a global institution, MDLA is confident in its ability to deliver sustainable value to all stakeholders and play a vital role in the future development of Indonesia’s healthcare industry.